Matthew Malenfant - Sep 1, 2022 Form 4 Insider Report for COVETRUS, INC. (CVET)

Role
Chief Commercial Officer
Signature
/s/ Margaret B. Pritchard, as attorney-in-fact for Matthew Malenfant
Stock symbol
CVET
Transactions as of
Sep 1, 2022
Transactions value $
-$158,877
Form type
4
Date filed
9/6/2022, 04:09 PM
Previous filing
Jun 3, 2022
Next filing
Oct 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVET Common Stock Options Exercise $0 +18.4K +28.36% $0.00 83.3K Sep 1, 2022 Direct
transaction CVET Common Stock Options Exercise $0 +6.99K +8.4% $0.00 90.3K Sep 1, 2022 Direct
transaction CVET Common Stock Options Exercise $0 +1.64K +1.82% $0.00 91.9K Sep 1, 2022 Direct
transaction CVET Common Stock Tax liability -$159K -7.63K -8.3% $20.82 84.3K Sep 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVET Restricted Stock Units Options Exercise $0 -18.4K -25% $0.00 55.2K Sep 1, 2022 Common Stock 18.4K Direct F1, F2
transaction CVET Restricted Stock Units Options Exercise $0 -6.99K -33% $0.00 14.2K Sep 1, 2022 Common Stock 6.99K Direct F1, F3
transaction CVET Restricted Stock Units Options Exercise $0 -1.64K -14.29% $0.00 9.86K Sep 1, 2022 Common Stock 1.64K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof.
F2 Subject to the Reporting Person's continuous service as an employee of the Issuer, the RSUs will vest 25% every six months in equal ratable increments.
F3 Subject to the Reporting Person's continuous service as an employee of the Issuer, the RSUs will vest 33% at the one-year anniversary of the grant date, then in equal ratable quarterly increments for the subsequent eight quarters.